UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Ironwood Pharmaceuticals
IRWD
$711M
| $12M | ﹤0.01% |
1,839,799
-1,187,916
| -39% | -$8.4M |
|
2077
PUT
AGNC Investment
AGNC
$12.9B
| $12M | ﹤0.01% |
+1,256,700
| New | +$12M |
|
2078
CALL
Cummins
CMI
$88.7B
| $12M | ﹤0.01% |
43,166
+7,966
| +23% | +$2.28M |
|
2079
Vanguard Russell 3000 ETF
VTHR
$4.85B
| $11.9M | ﹤0.01% |
49,778
+7,060
| +17% | +$1.64M |
|
|
CERE
2080
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $11.9M | ﹤0.01% |
291,457
-14,084
| -5% | -$587K |
|
2081
Tandem Diabetes Care
TNDM
$1.53B
| $11.9M | ﹤0.01% |
295,787
+255,065
| +626% | +$10.6M |
|
2082
Global X Silver Miners ETF NEW
SIL
$4.75B
| $11.9M | ﹤0.01% |
381,784
-52,253
| -12% | -$1.68M |
|
2083
iShares MSCI Singapore ETF
EWS
$1.08B
| $11.9M | ﹤0.01% |
+618,349
| New | +$11.8M |
|
2084
First Trust Materials AlphaDEX Fund
FXZ
$398M
| $11.9M | ﹤0.01% |
182,837
+31,809
| +21% | +$2.18M |
|
2085
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.72B
| $11.8M | ﹤0.01% |
210,209
+49,916
| +31% | +$2.76M |
|
2086
PUT
Mercado Libre
MELI
$92.3B
| $11.8M | ﹤0.01% |
7,200
+6,900
| +2,300% | +$10.9M |
|
2087
Invesco BulletShares 2031 Corporate Bond ETF
BSCV
$1.77B
| $11.8M | ﹤0.01% |
741,662
+50,313
| +7% | +$800K |
|
|
DFUS
2088
Dimensional US Equity ETF
DFUS
$21.6B
| $11.8M | ﹤0.01% |
199,669
+47,782
| +31% | +$2.72M |
|
2089
PUT
Spotify
SPOT
$100B
| $11.7M | ﹤0.01% |
37,400
-17,500
| -32% | -$5.27M |
|
2090
Sunrun
RUN
$2.46B
| $11.7M | ﹤0.01% |
989,394
+691,335
| +232% | +$8.47M |
|
2091
iShares AAA-A Rated Corporate Bond ETF
QLTA
$1.23B
| $11.7M | ﹤0.01% |
250,349
-21,816
| -8% | -$1.02M |
|
2092
Bilibili
BILI
$7.84B
| $11.7M | ﹤0.01% |
759,654
-727,981
| -49% | -$10.1M |
|
|
BLD
2093
DELISTED
TopBuild
BLD
| $11.7M | ﹤0.01% |
30,428
+3,150
| +12% | +$1.28M |
|
2094
CALL
Bath & Body Works
BBWI
$4.1B
| $11.7M | ﹤0.01% |
+300,000
| New | +$13.8M |
|
2095
Invesco BulletShares 2026 High Yield Corporate Bond ETF
BSJQ
$890M
| $11.7M | ﹤0.01% |
507,287
-600,868
| -54% | -$13.9M |
|
2096
PUT
Synopsys
SNPS
$79.7B
| $11.7M | ﹤0.01% |
19,600
+18,700
| +2,078% | +$10.6M |
|
2097
Globe Life
GL
$14.3B
| $11.6M | ﹤0.01% |
141,111
-75,080
| -35% | -$6.22M |
|
2098
Performance Food Group
PFGC
$18B
| $11.6M | ﹤0.01% |
175,600
+31,642
| +22% | +$2.21M |
|
2099
Trex
TREX
$5.01B
| $11.6M | ﹤0.01% |
156,495
+20,671
| +15% | +$1.81M |
|
2100
Vipshop
VIPS
$7.53B
| $11.6M | ﹤0.01% |
888,266
+85,149
| +11% | +$1.35M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.